In today’s era of sensitivity to health and healthcare cost issues, one frequent topic of discussion is end stage renal disease. In the U.S., the Center for Disease Control and Prevention found that chronic kidney disease affected almost 17% of the adult population during 1999 to 2004 and that number is growing. The purpose of this paper is to describe the definition, causes, treatment and financial implications of this disease.
Download full article as featured in the March 2013 edition of The Self-Insurer.
To start on a positive note. Life & Health insurers utilize a wealth of digitally sourced health data for risk analysis and employ digital underwriting […]
Dr. Achim Regenauer, Chief Medical Officer, discusses a newly published study that links air pollution to the occurrence of common neurodegenerative diseases, namely Alzheimer’s and […]